BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 24885028)

  • 1. Sequence artefacts in a prospective series of formalin-fixed tumours tested for mutations in hotspot regions by massively parallel sequencing.
    Wong SQ; Li J; Tan AY; Vedururu R; Pang JM; Do H; Ellul J; Doig K; Bell A; MacArthur GA; Fox SB; Thomas DM; Fellowes A; Parisot JP; Dobrovic A;
    BMC Med Genomics; 2014 May; 7():23. PubMed ID: 24885028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reducing sequence artifacts in amplicon-based massively parallel sequencing of formalin-fixed paraffin-embedded DNA by enzymatic depletion of uracil-containing templates.
    Do H; Wong SQ; Li J; Dobrovic A
    Clin Chem; 2013 Sep; 59(9):1376-83. PubMed ID: 23649127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of uracil DNA glycosylase pretreatment in amplicon-based massively parallel sequencing with DNA extracted from archived formalin-fixed paraffin-embedded esophageal cancer tissues.
    Serizawa M; Yokota T; Hosokawa A; Kusafuka K; Sugiyama T; Tsubosa Y; Yasui H; Nakajima T; Koh Y
    Cancer Genet; 2015 Sep; 208(9):415-27. PubMed ID: 26194062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dramatic reduction of sequence artefacts from DNA isolated from formalin-fixed cancer biopsies by treatment with uracil- DNA glycosylase.
    Do H; Dobrovic A
    Oncotarget; 2012 May; 3(5):546-58. PubMed ID: 22643842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequence artifacts in DNA from formalin-fixed tissues: causes and strategies for minimization.
    Do H; Dobrovic A
    Clin Chem; 2015 Jan; 61(1):64-71. PubMed ID: 25421801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of Targeted Next-generation Sequencing, TruSeq Custom Amplicon Assay for Molecular Pathology Diagnostics on Formalin-fixed and Paraffin-embedded Samples.
    Csernák E; Molnár J; Tusnády GE; Tóth E
    Appl Immunohistochem Mol Morphol; 2017 Aug; 25(7):460-466. PubMed ID: 26808133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limited copy number-high resolution melting (LCN-HRM) enables the detection and identification by sequencing of low level mutations in cancer biopsies.
    Do H; Dobrovic A
    Mol Cancer; 2009 Oct; 8():82. PubMed ID: 19811662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formalin fixation increases deamination mutation signature but should not lead to false positive mutations in clinical practice.
    Prentice LM; Miller RR; Knaggs J; Mazloomian A; Aguirre Hernandez R; Franchini P; Parsa K; Tessier-Cloutier B; Lapuk A; Huntsman D; Schaeffer DF; Sheffield BS
    PLoS One; 2018; 13(4):e0196434. PubMed ID: 29698444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using postmortem formalin fixed paraffin-embedded tissues for molecular testing of sudden cardiac death: A cautionary tale of utility and limitations.
    Lin Y; Gryazeva T; Wang D; Zhou B; Um SY; Eng LS; Ruiter K; Rojas L; Williams N; Sampson BA; Tang Y
    Forensic Sci Int; 2020 Mar; 308():110177. PubMed ID: 32155531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-reproducible sequence artifacts in FFPE tissue: an experience report.
    Ofner R; Ritter C; Ugurel S; Cerroni L; Stiller M; Bogenrieder T; Solca F; Schrama D; Becker JC
    J Cancer Res Clin Oncol; 2017 Jul; 143(7):1199-1207. PubMed ID: 28314930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PIK3CA mutation is a favorable prognostic factor in esophageal cancer: molecular profile by next-generation sequencing using surgically resected formalin-fixed, paraffin-embedded tissue.
    Yokota T; Serizawa M; Hosokawa A; Kusafuka K; Mori K; Sugiyama T; Tsubosa Y; Koh Y
    BMC Cancer; 2018 Aug; 18(1):826. PubMed ID: 30115035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation screening using formalin-fixed paraffin-embedded tissues: a stratified approach according to DNA quality.
    Cucco F; Clipson A; Kennedy H; Sneath Thompson J; Wang M; Barrans S; van Hoppe M; Ochoa Ruiz E; Caddy J; Hamid D; Cummin T; Burton C; Davies AJ; Johnson P; Du MQ
    Lab Invest; 2018 Aug; 98(8):1084-1092. PubMed ID: 29769698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the clinical value of targeted massively parallel sequencing in a longitudinal, prospective population-based study of cancer patients.
    Wong SQ; Fellowes A; Doig K; Ellul J; Bosma TJ; Irwin D; Vedururu R; Tan AY; Weiss J; Chan KS; Lucas M; Thomas DM; Dobrovic A; Parisot JP; Fox SB
    Br J Cancer; 2015 Apr; 112(8):1411-20. PubMed ID: 25742471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted or whole genome sequencing of formalin fixed tissue samples: potential applications in cancer genomics.
    Munchel S; Hoang Y; Zhao Y; Cottrell J; Klotzle B; Godwin AK; Koestler D; Beyerlein P; Fan JB; Bibikova M; Chien J
    Oncotarget; 2015 Sep; 6(28):25943-61. PubMed ID: 26305677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profiling cancer gene mutations in clinical formalin-fixed, paraffin-embedded colorectal tumor specimens using targeted next-generation sequencing.
    Zhang L; Chen L; Sah S; Latham GJ; Patel R; Song Q; Koeppen H; Tam R; Schleifman E; Mashhedi H; Chalasani S; Fu L; Sumiyoshi T; Raja R; Forrest W; Hampton GM; Lackner MR; Hegde P; Jia S
    Oncologist; 2014 Apr; 19(4):336-43. PubMed ID: 24664487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technical in-depth comparison of two massive parallel DNA-sequencing methods for formalin-fixed paraffin-embedded tissue from victims of sudden cardiac death.
    Adolfsson E; Qvick A; Gréen H; Kling D; Gunnarsson C; Jonasson J; Gréen A
    Forensic Sci Int Genet; 2021 Jul; 53():102522. PubMed ID: 33945952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HaloPlex Targeted Resequencing for Mutation Detection in Clinical Formalin-Fixed, Paraffin-Embedded Tumor Samples.
    Moens LN; Falk-Sörqvist E; Ljungström V; Mattsson J; Sundström M; La Fleur L; Mathot L; Micke P; Nilsson M; Botling J
    J Mol Diagn; 2015 Nov; 17(6):729-39. PubMed ID: 26354930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Next Generation Sequencing as a Reliable Diagnostic Assay for the Detection of Somatic Mutations in Tumours Using Minimal DNA Amounts from Formalin Fixed Paraffin Embedded Material.
    de Leng WW; Gadellaa-van Hooijdonk CG; Barendregt-Smouter FA; Koudijs MJ; Nijman I; Hinrichs JW; Cuppen E; van Lieshout S; Loberg RD; de Jonge M; Voest EE; de Weger RA; Steeghs N; Langenberg MH; Sleijfer S; Willems SM; Lolkema MP
    PLoS One; 2016; 11(2):e0149405. PubMed ID: 26919633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of different massive parallel sequencing platforms for mutation profiling in formalin-fixed and paraffin-embedded samples].
    Jiang RR; Wang YJ; Teng XD; Xiao L; Bu H; Ye F
    Zhonghua Bing Li Xue Za Zhi; 2018 Aug; 47(8):591-596. PubMed ID: 30107663
    [No Abstract]   [Full Text] [Related]  

  • 20. Towards standardization of next-generation sequencing of FFPE samples for clinical oncology: intrinsic obstacles and possible solutions.
    Ivanov M; Laktionov K; Breder V; Chernenko P; Novikova E; Telysheva E; Musienko S; Baranova A; Mileyko V
    J Transl Med; 2017 Jan; 15(1):22. PubMed ID: 28137276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.